DE3382086D1 - Pharmazeutische mixtur. - Google Patents

Pharmazeutische mixtur.

Info

Publication number
DE3382086D1
DE3382086D1 DE8383850147T DE3382086T DE3382086D1 DE 3382086 D1 DE3382086 D1 DE 3382086D1 DE 8383850147 T DE8383850147 T DE 8383850147T DE 3382086 T DE3382086 T DE 3382086T DE 3382086 D1 DE3382086 D1 DE 3382086D1
Authority
DE
Germany
Prior art keywords
pharmaceutical mixture
pharmaceutical
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383850147T
Other languages
English (en)
Inventor
Anders Goeran Vilh Kaellstrand
Kjell Johan Mattsson
Rolf Ivar Sjoeqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
AstraZeneca AB
Original Assignee
Astra AB
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB, Astra Lakemedel AB filed Critical Astra AB
Application granted granted Critical
Publication of DE3382086D1 publication Critical patent/DE3382086D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DE8383850147T 1982-06-24 1983-05-31 Pharmazeutische mixtur. Expired - Lifetime DE3382086D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture

Publications (1)

Publication Number Publication Date
DE3382086D1 true DE3382086D1 (de) 1991-02-07

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383850147T Expired - Lifetime DE3382086D1 (de) 1982-06-24 1983-05-31 Pharmazeutische mixtur.

Country Status (29)

Country Link
EP (1) EP0101418B1 (de)
JP (1) JPS5916822A (de)
KR (1) KR910000028B1 (de)
AR (1) AR231075A1 (de)
AT (1) ATE59286T1 (de)
AU (1) AU561954B2 (de)
BG (1) BG51341A3 (de)
CA (1) CA1214726A (de)
CS (1) CS257769B2 (de)
CY (1) CY1468A (de)
DD (1) DD209971A5 (de)
DE (1) DE3382086D1 (de)
DK (1) DK161365C (de)
ES (1) ES523536A0 (de)
FI (1) FI85213C (de)
GB (1) GB2122490B (de)
GR (1) GR78604B (de)
HK (1) HK98786A (de)
HU (1) HU189300B (de)
IE (1) IE55204B1 (de)
IS (1) IS1325B6 (de)
MY (1) MY8700292A (de)
NO (1) NO168745C (de)
NZ (1) NZ204639A (de)
PH (1) PH21911A (de)
PT (1) PT76919B (de)
SE (1) SE8203953D0 (de)
SU (1) SU1722207A3 (de)
ZA (1) ZA833931B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
JPH03504968A (ja) * 1988-04-19 1991-10-31 サウスウェスト・リサーチ・インスティチュート 塩感受性シェル物質を有するカプセルからの活性成分の制御放出
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
WO1996034628A1 (fr) * 1995-05-02 1996-11-07 Taisho Pharmaceutical Co., Ltd. Composition s'administrant par voie orale
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (de) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
NL7502121A (nl) * 1974-02-22 1975-08-26 Wellcome Found Werkwijze ter vervaardiging van een farmaceu- tisch preparaat dat digoxin bevat.
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
AU1594383A (en) 1984-01-05
JPH0559089B2 (de) 1993-08-30
IE831462L (en) 1983-12-24
DD209971A5 (de) 1984-05-30
SU1722207A3 (ru) 1992-03-23
NO168745C (no) 1992-04-01
CY1468A (en) 1989-07-21
ES8403720A1 (es) 1984-04-01
IS2824A7 (is) 1983-12-25
KR910000028B1 (ko) 1991-01-19
HK98786A (en) 1986-12-24
SE8203953D0 (sv) 1982-06-24
EP0101418A3 (en) 1984-11-14
FI85213B (fi) 1991-12-13
CA1214726A (en) 1986-12-02
HU189300B (en) 1986-06-30
GB8317071D0 (en) 1983-07-27
PH21911A (en) 1988-04-08
IE55204B1 (en) 1990-07-04
AR231075A1 (es) 1984-09-28
EP0101418B1 (de) 1990-12-27
IS1325B6 (is) 1988-08-03
ZA833931B (en) 1984-07-25
GB2122490A (en) 1984-01-18
JPS5916822A (ja) 1984-01-28
FI832197A0 (fi) 1983-06-16
NO832293L (no) 1983-12-27
MY8700292A (en) 1987-12-31
FI85213C (fi) 1992-03-25
PT76919A (en) 1983-07-01
GB2122490B (en) 1986-04-03
FI832197L (fi) 1983-12-25
KR840005024A (ko) 1984-11-03
CS257769B2 (en) 1988-06-15
EP0101418A2 (de) 1984-02-22
GR78604B (de) 1984-09-27
NO168745B (no) 1991-12-23
ATE59286T1 (de) 1991-01-15
NZ204639A (en) 1986-01-24
BG51341A3 (en) 1993-04-15
PT76919B (en) 1986-04-09
DK161365B (da) 1991-07-01
CS463683A2 (en) 1987-11-12
ES523536A0 (es) 1984-04-01
DK161365C (da) 1991-12-09
AU561954B2 (en) 1987-05-21
DK272383A (da) 1983-12-25
DK272383D0 (da) 1983-06-14

Similar Documents

Publication Publication Date Title
ATE22007T1 (de) Pharmazeutische mischung.
DE3486255T2 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3774264D1 (de) Pseudoephedrin-dosierungsform.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
ATE59286T1 (de) Pharmazeutische mixtur.
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
FI834888A (fi) Gonadoliberinderivat, foerfarande foer deras framstaellning och farmaceutiska och veterinaermedicinska blandningar framstaellda daerav.
DE3576117D1 (de) Mehrphasige pharmazeutische zusammensetzung.
NL188905C (nl) Anthracyclineverbinding en farmaceutisch preparaat.
NO882653D0 (no) Doseringsform.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872733A (fi) Farmaceutiska kompositioner.
DE68907177D1 (de) Dosierungsform.
FI872313A (fi) Farmaceutiska kompositioner.
FI883673A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition